Results 331 to 340 of about 236,526 (353)

Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis

Hepatology, 2022
Background and Aims: NAFLD and chronic hepatitis B (CHB) infection are common etiologies of HCC. The impact of hepatic steatosis on HCC in CHB, as well as its relationship with the development of cirrhosis, fibrosis, and HBsAg seroclearance, remains ...
Xianhua Mao, K. Cheung, Chengzhi Peng, L. Mak, H. Cheng, J. Fung, N. Peleg, H. Leung, Rajneesh Kumar, Jeong‐Hoon Lee, A. Shlomai, M. Yuen, W. Seto   +12 more
semanticscholar   +1 more source

Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis

Hepatology, 2018
Cyrielle Caussy, Veeral H Ajmera, Ricki Bettencourt   +2 more
exaly   +2 more sources

Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease

Gastroenterology, 2017
BACKGROUND & AIMS Magnetic resonance imaging (MRI) techniques and ultrasound-based transient elastography (TE) can be used in noninvasive diagnosis of fibrosis and steatosis in patients with nonalcoholic fatty liver disease (NAFLD).
Ricki Bettencourt, Jonathan C Hooker Bs, Ethan Sy   +2 more
exaly   +2 more sources

TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice.

Gastroenterology, 2020
BACKGROUND & AIMS Non-alcoholic fatty liver disease is characterized by excessive hepatic accumulation of triglycerides. We aimed to identify metabolites that differ in liver tissues of patients with liver steatosis vs healthy individuals (controls) and ...
Mingming Zhao, Lin Zhao, X. Xiong, Yuan He, Wei Huang, Zihao Liu, Liang Ji, Bing Pan, Xuefeng Guo, Leibo Wang, Si Cheng, Ming Xu, Hongyuan Yang, Yuxin Yin, Minerva T. Garcia-Barrio, Y. E. Chen, Xiangbao Meng, Lemin Zheng, Lemin Zheng   +18 more
semanticscholar   +1 more source

Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis

Nature Communications, 2019
Variations in N-acylethanolamines (NAE) levels are associated with obesity and metabolic comorbidities. Their role in the gut remains unclear. Therefore, we generated a mouse model of inducible intestinal epithelial cell (IEC)-specific deletion of N ...
Amandine Everard, Marialetizia Rastelli, Matthias Van Hul   +2 more
exaly   +2 more sources

Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease

Diabetes, obesity and metabolism, 2018
To investigate the effects of dapagliflozin on liver steatosis and fibrosis evaluated in patients with type 2 diabetes and non‐alcoholic fatty liver disease (NAFLD).
Masanori Shimizu, Kunihiro Suzuki, Kanako Kato, T. Jojima, Toshie Iijima, T. Murohisa, M. Iijima, H. Takekawa, Isao Usui, H. Hiraishi, Y. Aso   +10 more
semanticscholar   +1 more source

Microbiomics, Metabolomics, Predicted Metagenomics, and Hepatic Steatosis in a Population‐Based Study of 1,355 Adults

Hepatology, 2020
Previous small studies have appraised the gut microbiome (GM) in steatosis, but large‐scale studies are lacking. We studied the association of the GM diversity and composition, plasma metabolites, predicted functional metagenomics, and steatosis.
L. J. Alferink, D. Radjabzadeh, N. Erler, D. Vojinovic, C. Medina-Gomez, A. Uitterlinden, R. J. Knegt, N. Amin, M. A. Ikram, H. Janssen, J. K. Kiefte-de Jong, H. Metselaar, C. M. Duijn, R. Kraaij, S. Darwish Murad   +14 more
semanticscholar   +1 more source

Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection

Hepatology International, 2021
L. Mak, R. Hui, J. Fung, Fen Liu, D. Wong, Bofei Li, K. Cheung, M. Yuen, W. Seto   +8 more
semanticscholar   +1 more source

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.

Journal of Hepatology, 2017
T. Karlas, D. Petroff, M. Sasso, Jian-Gao Fan, Y. Mi, V. de Lédinghen, M. Kumar, M. Lupșor-Platon, K. Han, A. Cardoso, G. Ferraioli, W. Chan, V. Wong, R. Myers, K. Chayama, M. Friedrich-Rust, M. Beaugrand, F. Shen, J. Hiriart, S. Sarin, R. Badea, K. Jung, P. Marcellin, C. Fìlice, S. Mahadeva, G. Wong, P. Crotty, Keiichi Masaki, J. Bojunga, P. Bedossa, V. Keim, J. Wiegand   +31 more
semanticscholar   +1 more source

Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD

Nature Reviews Endocrinology, 2021
Nobuharu Tamaki, Veeral Ajmera
exaly